Research ArticleNeuropharmacology
In Vivo Occupancy of Dopamine D3 Receptors by Antagonists Produces Neurochemical and Behavioral Effects of Potential Relevance to Attention-Deficit–Hyperactivity Disorder
V. Barth, A. B. Need, E. T. Tzavara, B. Giros, C. Overshiner, S. D. Gleason, M. Wade, A. M. Johansson, K. Perry, G. G. Nomikos and J. M. Witkin
Journal of Pharmacology and Experimental Therapeutics February 2013, 344 (2) 501-510; DOI: https://doi.org/10.1124/jpet.112.198895
V. Barth
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana (V.B., A.B.N., C.O., S.D.G., M.W., A.M.J., K.P., G.G.N., J.M.W.); and INSERM U-952, Université Pierre et Marie Curie, Paris, France (E.T.T., B.G.)
A. B. Need
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana (V.B., A.B.N., C.O., S.D.G., M.W., A.M.J., K.P., G.G.N., J.M.W.); and INSERM U-952, Université Pierre et Marie Curie, Paris, France (E.T.T., B.G.)
E. T. Tzavara
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana (V.B., A.B.N., C.O., S.D.G., M.W., A.M.J., K.P., G.G.N., J.M.W.); and INSERM U-952, Université Pierre et Marie Curie, Paris, France (E.T.T., B.G.)
B. Giros
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana (V.B., A.B.N., C.O., S.D.G., M.W., A.M.J., K.P., G.G.N., J.M.W.); and INSERM U-952, Université Pierre et Marie Curie, Paris, France (E.T.T., B.G.)
C. Overshiner
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana (V.B., A.B.N., C.O., S.D.G., M.W., A.M.J., K.P., G.G.N., J.M.W.); and INSERM U-952, Université Pierre et Marie Curie, Paris, France (E.T.T., B.G.)
S. D. Gleason
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana (V.B., A.B.N., C.O., S.D.G., M.W., A.M.J., K.P., G.G.N., J.M.W.); and INSERM U-952, Université Pierre et Marie Curie, Paris, France (E.T.T., B.G.)
M. Wade
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana (V.B., A.B.N., C.O., S.D.G., M.W., A.M.J., K.P., G.G.N., J.M.W.); and INSERM U-952, Université Pierre et Marie Curie, Paris, France (E.T.T., B.G.)
A. M. Johansson
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana (V.B., A.B.N., C.O., S.D.G., M.W., A.M.J., K.P., G.G.N., J.M.W.); and INSERM U-952, Université Pierre et Marie Curie, Paris, France (E.T.T., B.G.)
K. Perry
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana (V.B., A.B.N., C.O., S.D.G., M.W., A.M.J., K.P., G.G.N., J.M.W.); and INSERM U-952, Université Pierre et Marie Curie, Paris, France (E.T.T., B.G.)
G. G. Nomikos
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana (V.B., A.B.N., C.O., S.D.G., M.W., A.M.J., K.P., G.G.N., J.M.W.); and INSERM U-952, Université Pierre et Marie Curie, Paris, France (E.T.T., B.G.)
J. M. Witkin
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana (V.B., A.B.N., C.O., S.D.G., M.W., A.M.J., K.P., G.G.N., J.M.W.); and INSERM U-952, Université Pierre et Marie Curie, Paris, France (E.T.T., B.G.)
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleNeuropharmacology
Occupancy of D3 Receptors and ADHD
V. Barth, A. B. Need, E. T. Tzavara, B. Giros, C. Overshiner, S. D. Gleason, M. Wade, A. M. Johansson, K. Perry, G. G. Nomikos and J. M. Witkin
Journal of Pharmacology and Experimental Therapeutics February 1, 2013, 344 (2) 501-510; DOI: https://doi.org/10.1124/jpet.112.198895
Research ArticleNeuropharmacology
Occupancy of D3 Receptors and ADHD
V. Barth, A. B. Need, E. T. Tzavara, B. Giros, C. Overshiner, S. D. Gleason, M. Wade, A. M. Johansson, K. Perry, G. G. Nomikos and J. M. Witkin
Journal of Pharmacology and Experimental Therapeutics February 1, 2013, 344 (2) 501-510; DOI: https://doi.org/10.1124/jpet.112.198895
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement